Kerry Fraser: Finding a 'New Normal' After a Cancer Diagnosis

Article

Retired NHL referee Kerry Fraser explained how rest and exercise both factor into his “new normal” after receiving a diagnosis of essential thrombocythemia in 2017.

During our discussion for the CURE Talks Cancer podcast, retired NHL referee Kerry Fraser explained how rest and exercise both factor into his “new normal” after receiving a diagnosis of essential thrombocythemia in 2017.

Transcription:

CURE: How did you get used to your "new normal" after being diagnosed?

Fraser: That's a great question, because there are times when we go along. It's been two years, pretty much, since I've been diagnosed, and you work at it, and for me, one of the side effects was fatigue. I'm a "go-go-go," an Energizer bunny kind of guy. But I found with this at some point in a month, or in a week, I'd hit the wall, and I would have to go down. I just couldn't fight it off. When I needed to rest, I rested. It could be 12 to 14 hours, but it recharged the batteries, and away I'd go again.

The one thing that I found is that exercise really helps. It helps me mentally and physically. It recharges the batteries no differently than when I refereed. If I flew out to Los Angeles and I was going to be on a 10-day trip out there, and I was tired from being at home and my wife and I have seven children, so consequently, I was usually tired when I left home. But rather than go to bed out there, the first thing I did was put on my gym gear and go down and ride the bike. That's kind of the mindset that I have now. I typically do a 10- to 12-mile ride at a good clip. I monitor my heart rate so that my training zone as a referee was 165 to 168 beats per minute.

I'm now 67 years old. I still train in the 155 to 158 beats per minute range, which kind of scared my hematologist, but he said, "Hey, if you're doing it, and you're used to doing it, keep doing it."

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE